The Research Assistant will assist with the recruitment and interviewing of participants in a project that focuses on the health and wellbeing of trans and gender nonbinary individuals.
The Research Assistant will be responsible for the following:
- Screen participants over the phone
- Responds to questions about the study protocol and procedures
- Schedules remote and in-person research activities and communicates with participants
- Follows up with research participants and tracks retention efforts
- Collects study information using web-based data collection software
- Conducts both remote and in-person structured interviews with research participants
- Maintains complete and accurate records and files
- Successful candidates must have a BA degree and a minimum of 2 years of relevant research experience in a medical or social science research environment. In addition, the candidate must have the following experience or training:
- Knowledge of and experience in working with trans and gender nonbinary communities
- Experience with recruitment efforts
- Excellent interpersonal and communication skills
- Basic computer skills such as web-based data collection, word processing, and database management
- Highly organized with a strong attention to detail
- Ability to work independently under limited supervision
- Willingness and ability to travel locally
- Bilingual (Spanish/English) preferred
Additional Qualifications: Knowledge of and experience in working with gender-diverse communities and with organizations concerned about the health and wellbeing of transgender and gender nonbinary (TGNB) individuals required. Excellent verbal and written communication skills with both research participants and staff required. Attention to detail is essential. Computer proficiency required. Capacity to multi-task and prioritize appropriately.
In accordance with NYS Office of Mental Health regulations, RFMH employees at NYSPI are required to be vaccinated with at least one dose of vaccine against COVID-19 by Monday, November 1st, 2021, and to be fully vaccinated by December 10, 2021.